Results 111 to 120 of about 34,871 (236)

Diagnosis and surgical treatment of four radiographically incomplete, articular, proximal third metatarsal bone fractures

open access: yesEquine Veterinary Education, EarlyView.
Summary The objective was to describe the diagnosis, surgical repair and outcome of four radiographically incomplete, articular, proximal third metatarsal bone fractures with an uncommon, dorsomedial–plantarolateral oblique configuration and this is a retrospective analysis of four racehorses presenting for surgical treatment of this uncommon fracture ...
M. J. S. Duggan   +5 more
wiley   +1 more source

Nanomaterial‐Mediated Radiotherapy–Immunotherapy Combinations: Breaking Immunosuppression and Revolutionizing Cancer Treatment

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 3, September 2026.
Nanomaterials integrate radiotherapy and immunotherapy by enhancing radiosensitivity, remodeling the immunosuppressive tumor microenvironment, and promoting systemic antitumor immunity. This review summarizes the latest strategies of nanomaterial‐mediated combinations (RT, immunotherapy, IRT) and highlights future directions for overcoming clinical ...
Peijie Li, Xiangqin Wang, Sisi He, Hu Ma
wiley   +1 more source

Increased Binding of [18F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease Brain

open access: yesSynapse, Volume 80, Issue 5, September 2026.
[18F]Nifene, a PET imaging probe for α4β2* nicotinic acetylcholine receptors, was used to discretely measure changes in hippocampus (HP) and subiculum (SUB) of postmortem Parkinson's disease (PD) cases compared to cognitively normal (CN) cases. Significant increased [18F]nifene binding in PD was observed.
Jogeshwar Mukherjee   +5 more
wiley   +1 more source

Hydrazine Derivatives as a Platform for Site-Specific Labelling of Peptides for in vivo Molecular Imaging of Disease [PDF]

open access: yes
The 6-hydrazinonicotinyl group, known as HYNIC, is an attractive bifunctional coupling agent for preparing 99mTc-labeled peptides and proteins for medical imaging.
Holland, Charlotte
core  

Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review [PDF]

open access: yes, 2019
Diagnostic radiopharmaceuticals used in nuclear medicine can cause adverse events. Information on these adverse events is available in case reports and databases but may not be readily accessible to healthcare professionals.
Jager, Pieter L.   +7 more
core   +1 more source

Scanner‐agnostic artificial intelligence approach for fast bone scintigraphy

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 8, August 2026.
Abstract Purpose Current bone scintigraphy protocols often demand full‐count, 10–15 min scans to preserve image quality, and existing deep‐learning (DL) denoisers typically need to be retrained or retuned for each camera manufacturer. We introduce a scanner‐agnostic adaptive‐diffusion U‐Net designed to reconstruct diagnostic‐grade images from half‐time
Vinicius de Oliveira Menezes   +9 more
wiley   +1 more source

Classification of tau status with machine learning models in amyloid‐positive cohorts

open access: yesAlzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract INTRODUCTION Although tau positron emission tomography (PET) imaging is effective for staging tau pathology, it is limited clinically by cost and availability. Machine learning models based on magnetic resonance imaging (MRI)– and amyloid PET–derived features may serve as useful screening tools for tau pathology.
Yun‐Chi Lin   +4 more
wiley   +1 more source

Chelator‐Free Radiometal Labeling Inside Engineered Affibodies

open access: yesAngewandte Chemie, Volume 138, Issue 30, 20 July 2026.
Affibodies are compact and robust three‑helix binders used in imaging and therapy. Engineering a triple‑cysteine motif into their core enables chelator‑free binding of important radiometals, like Bi(III), Pb(II), In(III), and Ga(III) with rapid uptake and exceptional stability.
Lani J. Davies   +6 more
wiley   +2 more sources

Staging lung cancer: total-body PET/CT or whole-body PET/CT?

open access: yesEJNMMI Research
Background Total Body PET/CT is increasingly used in clinical practice, but its benefits for lung cancer staging are not fully established. This study aimed to evaluate the impact of Total Body PET/CT on lung cancer staging compared to traditional Whole ...
Xiaoxiang Zhang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy